| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3684 | nocazine C | Nocazine family member |
|
| DCC3685 | nocazine E | Marine natural nocazine family member; Standard used in nocazine biosynthetic parthway studies |
|
| DCC3686 | Nociceptin | Neuropeptide, acting as a endogenous ligand for the nociceptin receptor (NOP, ORL-1) |
|
| DCC3687 | N-oleoylethanolamine | PPARalpha agonist and EC 3.5.1.23 (ceramidase) inhibitor |
|
| DCC3688 | Nomegestrol | Steroidal progestin |
|
| DCC3689 | Nomegestrol Acetate | Neutral, nonandrogenic, progesterone-like profile progestin |
|
| DCC3690 | Nonoxynol-9 | Novel human epidermal growth factor receptor-2 (HER2) inhibitor; Spermatocide |
|
| DCC3691 | Nord-1 | Novel red-light-controllable nitric oxide (NO) releaser |
|
| DCC3692 | Nor-fauc-365 | FAUC-365 analog |
|
| DCC3693 | Norgestomet | Steroidal progestin used in veterinary medicine to control estrus and ovulation in cattle |
|
| DCC3694 | Noricumazole A | Secondary metabolite from the myxobacterium Sorangium cellulosum, acting as a potent HCV inhibitor, Ebola virus (EBOV) entry inhibitor, and a potassium channel inhibitor |
|
| DCC3695 | No-rosa5 | Controllable nitric oxide (NO) donor, releasing NO triggered by photoinduced electron transfer (PeT) |
|
| DCC3696 | Noscapine | Natueal sigma receptor agonist, attenuating cytokine release associated with SARS-CoV-2, also being used as anti-malarial, anti-stroke and cough-suppressant |
|
| DCC3697 | Notum-in-23dd | Novel potent inhibitor of notum carboxylesterase activity |
|
| DCC3698 | Notum-in-24 | Novel potent notum inhibitor (OPTS IC50 3.6nM; TCF-LEF EC50 220nM), showing good plasma exposure and reasonable CNS penetration |
|
| DCC3699 | Nov-lrrk2-11 | Novel potent LRRK2 inhibitor |
|
| DCC3700 | Novolactone | Natural inhibitor of the allosteric regulation of Hsp70 |
|
| DCC3701 | Np-005497 | Natural inhibitor of jasmonate signaling targets JAR1 in Arabidopsis thaliana |
|
| DCC3702 | Npa101.3 | Second-Generation RET/VEGFR2 Inhibitor |
|
| DCC3703 | Np-c86 | Novel stabilizer of long noncoding RNA (lncRNA) GAS5, binding to GAS5 with high affinity, and increasing GAS5 levels and glucose uptake in diabetic patient adipocytes |
|
| DCC3704 | Npd-008 | Novel Inhibitor of Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) |
|
| DCC3705 | Npd-039 | Novel Inhibitor of Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) |
|
| DCC3706 | Npd-048 | Novel inhibitor of Trypanosoma brucei PDEB1 (TbrPDEB1) |
|
| DCC3707 | Npd11033 | Novel selective SIRT2 inhibitor, creating a hydrophobic cavity behind the substrate-binding pocket after a conformational change of the Zn-binding small domain of SIRT2 |
|
| DCC3708 | Npd12671 | Novel activator of 15-ADON production, significantly increasing the transcription of Tri6, a transcription factor gene necessary for trichothecene biosynthesis, in both trichothecene-inducing and noninducing culture conditions |
|
| DCC3709 | Npd2639 | Novel biomediator, inducing reveromycin production in Streptomyces sp. SN-593 |
|
| DCC3710 | Npd6689 | Novel tubulin inhibitor |
|
| DCC3711 | Npd7155 | Novel competitive MTH1 inhibitor |
|
| DCC3712 | Npd8617 | Novel tubulin inhibitor |
|
| DCC3713 | Npd9055 | Novel heterotrimeric G-protein Gi modulator, inhibiting GDP/GTP exchange on a Gαi subunit induced by a G-protein-coupled receptor agonist, but not on another G-protein from the Gαs family, regulating Gβγ-dependent cellular processes, most likely by causin |
|
